Insider Trading › TFFP › Insiders
TFFP
TFFP·Insider activity
$0.07
+0.00 (+0.00%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
TFFP
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
TFFPS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of TFFP were filed in the last 180 days. Newest filing Aug 17, 2023 (3 years ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by TFFP insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
72Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of TFFP common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
72 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Carlson Clint Duane10% owner | Sale | −1,000 | $0.39 | $390 | 5.1Mindirect | Aug 16, 2023 | Aug 17, 2023 | Form 4 ↗ |
| Carlson Clint Duane10% owner | Sale | −215.0K | $0.44 | $95K | 5.1Mindirect | Aug 15, 2023 | Aug 17, 2023 | Form 4 ↗ |
| Weisman Harlan FPresident and CEO · Director | Purchase | +600.0K | n/c | — | 814.6Kdirect | Aug 15, 2023 | Aug 15, 2023 | Form 4 ↗ |
| ROCAMBOLI STEPHENDirector | Purchase | +20.0K | n/c | — | 36.0Kdirect | Aug 15, 2023 | Aug 15, 2023 | Form 4 ↗ |
| Roberts BrandiDirector | Purchase | +20.0K | n/c | — | 20.0Kdirect | Aug 15, 2023 | Aug 15, 2023 | Form 4 ↗ |
| MILLS ROBERT SDirector | Purchase | +40.0K | n/c | — | 56.0Kdirect | Aug 15, 2023 | Aug 15, 2023 | Form 4 ↗ |
| COLEMAN KIRK ALLENChief Financial Officer | Purchase | +20.0K | n/c | — | 35.7Kdirect | Aug 15, 2023 | Aug 15, 2023 | Form 4 ↗ |
| Mikhak ZamanehChief Medical Officer | Purchase | +120.0K | n/c | — | 135.0Kdirect | Aug 15, 2023 | Aug 15, 2023 | Form 4 ↗ |
| ROCAMBOLI STEPHENDirector | Purchase | +13.0K | $0.80 | $10K | 16.0Kdirect | Mar 10, 2023 | Mar 13, 2023 | Form 4 ↗ |
| COLEMAN KIRK ALLENChief Financial Officer | Purchase | +12.0K | $0.79 | $9K | 15.7Kdirect | Mar 10, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Weisman Harlan FPresident and CEO · Director | Purchase | +150.0K | $0.88 | $132K | 214.6Kdirect | Mar 10, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Mikhak ZamanehChief Medical Officer | Purchase | +15.0K | $0.82 | $12K | 15.0Kdirect | Mar 10, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Weisman Harlan FPresident and CEO · Director | Purchase | +50.0K | $1.06 | $53K | 64.6Kdirect | Dec 15, 2022 | Dec 19, 2022 | Form 4 ↗ |
| Fletcher Aaron G.L.Director | Purchase | +43.5K | $1.15 | $50K | 143.5Kdirect | Nov 22, 2022 | Nov 23, 2022 | Form 4 ↗ |
| THURMAN RANDY HDirector | Sale | −40.3K | $4.29 | $173K | 0direct | Sep 29, 2022 | Sep 30, 2022 | Form 4 ↗ |
| Weisman Harlan FDirector | Purchase | +4,615 | $5.50 | $25K | 14.6Kdirect | May 20, 2022 | May 20, 2022 | Form 4 ↗ |
| Weisman Harlan FDirector | Purchase | +2,500 | $5.12 | $13K | 10.0Kdirect | May 18, 2022 | May 20, 2022 | Form 4 ↗ |
| Fletcher Aaron G.L.Director | Purchase | +24.6K | $5.08 | $125K | 109.6Kindirect | May 17, 2022 | May 17, 2022 | Form 4 ↗ |
| COLEMAN KIRK ALLENChief Financial Officer | Purchase | +425 | $4.83 | $2K | 3,675direct | May 17, 2022 | May 17, 2022 | Form 4 ↗ |
| Fletcher Aaron G.L.Director | Purchase | +85.0K | $4.86 | $413K | 85.0Kindirect | May 16, 2022 | May 17, 2022 | Form 4 ↗ |
| Weisman Harlan FDirector | Purchase | +2,500 | $4.74 | $12K | 7,500direct | May 16, 2022 | May 17, 2022 | Form 4 ↗ |
| COLEMAN KIRK ALLENChief Financial Officer | Purchase | +1,250 | $4.40 | $6K | 3,250direct | May 16, 2022 | May 17, 2022 | Form 4 ↗ |
| Mattes Glenn R.President and CEO · Director | Purchase | +16.0K | $4.78 | $76K | 36.0Kdirect | May 16, 2022 | May 17, 2022 | Form 4 ↗ |
| ROCAMBOLI STEPHENDirector | Purchase | +3,000 | $4.54 | $14K | 18.7Kdirect | May 16, 2022 | May 17, 2022 | Form 4 ↗ |
| Fletcher Aaron G.L.Director | Purchase | +42.0K | $6.89 | $289K | 542.0Kindirect | Apr 4, 2022 | Apr 4, 2022 | Form 4 ↗ |
| Fletcher Aaron G.L.Director | Purchase | +500.0K | $6.43 | $3.2M | 500.0Kindirect | Apr 4, 2022 | Apr 4, 2022 | Form 4 ↗ |
| Mattes Glenn R.President and CEO · Director | Purchase | +10.0K | $7.10 | $71K | 20.0Kdirect | Sep 16, 2021 | Sep 16, 2021 | Form 4 ↗ |
| COLEMAN KIRK ALLENCFO, Secretary and Treasurer | Purchase | +1,000 | $7.30 | $7K | 2,000direct | Sep 16, 2021 | Sep 16, 2021 | Form 4 ↗ |
| Fairbairn MalcolmDirector | Purchase | +10.0K | $8.95 | $90K | 10.0Kindirect | May 19, 2021 | May 19, 2021 | Form 4 ↗ |
| THURMAN RANDY HDirector | Purchase | +1,050 | $9.40 | $10K | 1,050direct | May 18, 2021 | May 19, 2021 | Form 4 ↗ |
| Lung Therapeutics, Inc.10% owner | Sale | −715.0K | $14.00 | $10.0M | 2.2Mdirect | Mar 26, 2021 | Mar 30, 2021 | Form 4 ↗ |
| ROCAMBOLI STEPHENDirector | Sale | −20.0K | $16.85 | $337K | 15.7Kdirect | Mar 15, 2021 | Mar 17, 2021 | Form 4 ↗ |
| Mattes Glenn R.President and CEO · Director | Sale | −50.0K | $17.04 | $852K | 10.0Kdirect | Mar 15, 2021 | Mar 17, 2021 | Form 4 ↗ |
| COLEMAN KIRK ALLENCFO, Secretary and Treasurer | Sale | −5,000 | $17.05 | $85K | 1,000direct | Mar 15, 2021 | Mar 17, 2021 | Form 4 ↗ |
| Mattes Glenn R.President and CEO · Director | Sale | −40.0K | $16.82 | $673K | 10.0Kdirect | Feb 16, 2021 | Feb 18, 2021 | Form 4 ↗ |
| COLEMAN KIRK ALLENCFO, Secretary and Treasurer | Sale | −5,000 | $16.82 | $84K | 1,000direct | Feb 16, 2021 | Feb 18, 2021 | Form 4 ↗ |
| MILLS ROBERT SDirector | Sale | −700 | $20.16 | $14K | 16.0Kdirect | Feb 10, 2021 | Feb 12, 2021 | Form 4 ↗ |
| MILLS ROBERT SDirector | Sale | −12.6K | $20.20 | $255K | 16.0Kdirect | Jan 20, 2021 | Jan 20, 2021 | Form 4 ↗ |
| MILLS ROBERT SDirector | Sale | −55.1K | $19.56 | $1.1M | 16.0Kdirect | Jan 19, 2021 | Jan 20, 2021 | Form 4 ↗ |
| Mattes Glenn R.President and CEO · Director | Sale | −40.0K | $17.51 | $700K | 10.0Kdirect | Jan 15, 2021 | Jan 20, 2021 | Form 4 ↗ |
| COLEMAN KIRK ALLENCFO, Secretary and Treasurer | Sale | −5,000 | $17.50 | $88K | 1,000direct | Jan 15, 2021 | Jan 20, 2021 | Form 4 ↗ |
| Mattes Glenn R.President and CEO · Director | Sale | −30.0K | $15.33 | $460K | 10.0Kdirect | Dec 23, 2020 | Dec 29, 2020 | Form 4 ↗ |
| COLEMAN KIRK ALLENCFO, Secretary and Treasurer | Sale | −10.0K | $15.24 | $152K | 1,000direct | Dec 23, 2020 | Dec 29, 2020 | Form 4 ↗ |
| MILLS ROBERT SDirector | Sale | −22.8K | $14.58 | $332K | 16.0Kdirect | Dec 11, 2020 | Dec 15, 2020 | Form 4 ↗ |
| WINDSOR JAMES BRIANChief Science Officer · Director | Sale | −25.0K | $15.80 | $395K | 5,000direct | Dec 7, 2020 | Dec 9, 2020 | Form 4 ↗ |
| Lung Therapeutics, Inc.10% owner | Sale | −250.0K | n/c | — | 3.0Mdirect | Dec 4, 2020 | Dec 8, 2020 | Form 4 ↗ |
| Lung Therapeutics, Inc.10% owner | Sale | −300.0K | n/c | — | 3.2Mdirect | Dec 4, 2020 | Dec 8, 2020 | Form 4 ↗ |
| Lung Therapeutics, Inc.10% owner | Sale | −500.0K | n/c | — | 3.5Mdirect | Dec 4, 2020 | Dec 8, 2020 | Form 4 ↗ |
| Fletcher Aaron G.L.Director | Purchase | +5,000 | $15.13 | $76K | 100.0Kdirect | Nov 24, 2020 | Nov 24, 2020 | Form 4 ↗ |
| THURMAN RANDY HDirector | Sale | −5,000 | $17.17 | $86K | 0direct | Nov 13, 2020 | Nov 13, 2020 | Form 4 ↗ |
| Fairbairn MalcolmDirector | Sale | −11.7K | $15.97 | $186K | 0indirect | Nov 12, 2020 | Nov 13, 2020 | Form 4 ↗ |
| Fairbairn MalcolmDirector | Sale | −63.3K | $15.93 | $1.0M | 11.7Kindirect | Nov 11, 2020 | Nov 13, 2020 | Form 4 ↗ |
| THURMAN RANDY HDirector | Sale | −34.5K | $15.91 | $549K | 5,000direct | Nov 11, 2020 | Nov 13, 2020 | Form 4 ↗ |
| ROCAMBOLI STEPHENDirector | Sale | −15.7K | $15.76 | $248K | 0direct | Nov 11, 2020 | Nov 13, 2020 | Form 4 ↗ |
| ROCAMBOLI STEPHENDirector | Sale | −21.3K | $15.14 | $322K | 0direct | Nov 10, 2020 | Nov 13, 2020 | Form 4 ↗ |
| COLEMAN KIRK ALLENCFO, Secretary, and Treasurer | Sale | −15.0K | $15.12 | $227K | 1,000direct | Nov 10, 2020 | Nov 13, 2020 | Form 4 ↗ |
| Mattes Glenn R.President and CEO · Director | Sale | −108.8K | $15.00 | $1.6M | 10.0Kdirect | Nov 10, 2020 | Nov 13, 2020 | Form 4 ↗ |
| Mattes Glenn R.President and CEO · Director | Sale | −3,000 | $17.00 | $51K | 7,000indirect | Sep 25, 2020 | Jan 20, 2021 | Form 4 ↗ |
| Fletcher Aaron G.L.Director | Purchase | +20.0K | $5.08 | $102K | 95.0Kdirect | May 26, 2020 | May 26, 2020 | Form 4 ↗ |
| Fletcher Aaron G.L.Director | Purchase | +5,581 | $4.72 | $26K | 75.0Kdirect | Apr 15, 2020 | Apr 17, 2020 | Form 4 ↗ |
| Fletcher Aaron G.L.Director | Purchase | +6,252 | $4.24 | $27K | 69.4Kdirect | Apr 6, 2020 | Apr 6, 2020 | Form 4 ↗ |
| Fletcher Aaron G.L.Director | Purchase | +16.7K | $3.97 | $66K | 63.2Kdirect | Apr 3, 2020 | Apr 6, 2020 | Form 4 ↗ |
| Fletcher Aaron G.L.Director | Purchase | +500 | $3.75 | $2K | 46.4Kdirect | Apr 2, 2020 | Apr 6, 2020 | Form 4 ↗ |
| Mattes Glenn R.President and CEO · Director | Purchase Amended | +10.0K | $5.00 | $50K | 10.0Kindirect | Oct 25, 2019 | Oct 30, 2019 | Form 4 ↗ |
| Mattes Glenn R.President and CEO · Director | Purchase Amended | +10.0K | $5.00 | $50K | 10.0Kdirect | Oct 25, 2019 | Oct 30, 2019 | Form 4 ↗ |
| WINDSOR JAMES BRIANChief Science Officer · Director | Purchase | +5,000 | $5.00 | $25K | 5,000direct | Oct 25, 2019 | Oct 29, 2019 | Form 4 ↗ |
| Weisman Harlan FDirector | Purchase | +5,000 | $5.00 | $25K | 5,000direct | Oct 25, 2019 | Oct 29, 2019 | Form 4 ↗ |
| THURMAN RANDY HDirector | Purchase | +5,000 | $5.00 | $25K | 5,000direct | Oct 25, 2019 | Oct 29, 2019 | Form 4 ↗ |
| MILLS ROBERT SDirector | Purchase | +5,000 | $5.00 | $25K | 5,000direct | Oct 25, 2019 | Oct 29, 2019 | Form 4 ↗ |
| Mattes Glenn R.President and CEO · Director | Purchase | +10.0K | $5.00 | $50K | 10.0Kdirect | Oct 25, 2019 | Oct 29, 2019 | Form 4 ↗ |
| Fletcher Aaron G.L.Director | Purchase | +2,000 | $5.00 | $10K | 2,000direct | Oct 25, 2019 | Oct 29, 2019 | Form 4 ↗ |
| COLEMAN KIRK ALLENCFO, Secretary, and Treasurer | Purchase | +1,000 | $5.00 | $5K | 1,000direct | Oct 25, 2019 | Oct 29, 2019 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →